{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:11:15Z","timestamp":1792066275898,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cgh.2013.05.020","type":"journal-article","created":{"date-parts":[[2013,6,2]],"date-time":"2013-06-02T09:04:48Z","timestamp":1370163888000},"page":"187-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["New Anticoagulant and Antiplatelet Agents: A Primer for the Gastroenterologist"],"prefix":"10.1016","volume":"12","author":[{"given":"Todd H.","family":"Baron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"McBane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.05.020_bib1","first-page":"e2","article-title":"American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2013.05.020_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mayocp.2013.03.006","article-title":"The new oral anticoagulants in clinical practice","volume":"88","author":"Gonsalves","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cgh.2013.05.020_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0030-1256317","article-title":"European Society of Gastrointestinal Endoscopy. Endoscopy and antiplatelet agents","volume":"43","author":"Bousti\u00e8re","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2013.05.020_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.gie.2009.09.040","article-title":"Management of antithrombotic agents for endoscopic procedures","volume":"70","author":"Anderson","year":"2009","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cgh.2013.05.020_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gut.2007.142497","article-title":"British Society of Gastroenterology; British Committee for Standards in Haematology; British Cardiovascular Intervention Society. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures","volume":"57","author":"Veitch","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2013.05.020_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","volume":"104","author":"Si\u00e9","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cgh.2013.05.020_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1160\/TH10-04-0217","volume":"105","author":"Peri Korte","year":"2011","journal-title":"Thromb Haemost"},{"issue":"Suppl","key":"10.1016\/j.cgh.2013.05.020_bib8","doi-asserted-by":"crossref","first-page":"e326S","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2013.05.020_bib9","doi-asserted-by":"crossref","first-page":"e120S","DOI":"10.1378\/chest.11-2294","article-title":"New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Weitz","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2013.05.020_bib10","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2013.05.020_bib11","first-page":"45S","article-title":"Reversal of drug-induced anticoagulation: old solutions and new problems","volume":"52","author":"Dzik","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.cgh.2013.05.020_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/ATVBAHA.111.242834","article-title":"A new generation of oral direct anticoagulants","volume":"32","author":"Soff","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl","key":"10.1016\/j.cgh.2013.05.020_bib13","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Guyatt","year":"2012","journal-title":"Chest"},{"issue":"Suppl","key":"10.1016\/j.cgh.2013.05.020_bib14","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2013.05.020_bib15","unstructured":"U.S. Food and Drug Administration News & Events. Available: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm350026.htm. Accessed: April 30, 2013."},{"key":"10.1016\/j.cgh.2013.05.020_bib16","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1002\/ajh.23202","article-title":"Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors","volume":"87","author":"Kaatz","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cgh.2013.05.020_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.amjcard.2012.03.049","article-title":"Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation","volume":"110","author":"Miller","year":"2012","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2013.05.020_bib18","first-page":"353","article-title":"The laboratory and the new oral anticoagulants","volume":"130","author":"Tripodi","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2013.05.020_bib19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2146\/ajhp110725","article-title":"Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient","volume":"69","author":"Miyares","year":"2012","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cgh.2013.05.020_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.12052","article-title":"Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology","volume":"159","author":"Baglin","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cgh.2013.05.020_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2013.05.020_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0032-1326788","article-title":"Approaches to diagnosing and managing anticoagulant-related bleeding","volume":"38","author":"Goy","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cgh.2013.05.020_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMp1302834","article-title":"Dabigatran and postmarketing reports of bleeding","volume":"368","author":"Southworth","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2013.05.020_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cgh.2012.10.021","article-title":"Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial","volume":"11","author":"Bytzer","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.05.020_bib25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1161\/CIRCULATIONAHA.110.004424","article-title":"Dabigatran etexilate: a new oral thrombin inhibitor","volume":"123","author":"Hankey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2013.05.020_bib26","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2012.02.008","article-title":"New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper","volume":"59","author":"De Caterina","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2013.05.020_bib27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrneph.2012.160","article-title":"Anticoagulants in atrial fibrillation patients with chronic kidney disease","volume":"8","author":"Hart","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cgh.2013.05.020_bib28","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1097\/SLE.0b013e31825af5a2","article-title":"Prophylactic clip application before endoscopic resection of large pedunculated colorectal polyps in patients receiving anticoagulation or antiplatelet medications","volume":"22","author":"Katsinelos","year":"2012","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.cgh.2013.05.020_bib29","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3748\/wjg.15.1973","article-title":"Colonoscopic polypectomy in anticoagulated patients","volume":"15","author":"Friedland","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.05.020_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0031-1291387","article-title":"Safety of cold polypectomy for <10mm polyps at colonoscopy: a prospective multicenter study","volume":"44","author":"Repici","year":"2012","journal-title":"Endoscopy"},{"key":"10.1016\/j.cgh.2013.05.020_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1440-1746.2011.06912.x","article-title":"Endoscopic papillary balloon dilatation versus endoscopic sphincterotomy in the treatment for choledocholithiasis: a meta-analysis","volume":"27","author":"Liu","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.05.020_bib32","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1160\/TH12-03-0209","article-title":"Management consensus guidance for the use of rivaroxaban - an oral, direct factor Xa inhibitor","volume":"108","author":"Turpie","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2013.05.020_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1160\/TH11-11-0804","article-title":"Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate","volume":"107","author":"Douxfils","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2013.05.020_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/clc.22037","article-title":"Emergency management of bleeding associated with old and new oral anticoagulants","volume":"35","author":"Frank Peacock","year":"2012","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cgh.2013.05.020_bib35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2013.05.020_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCOUTCOMES.112.966572","article-title":"Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation","volume":"5","author":"Baker","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.cgh.2013.05.020_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/AAP.0b013e3181c15c70","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (third edition)","volume":"35","author":"Horlocker","year":"2010","journal-title":"Reg Anesth Pain Med"},{"issue":"Suppl","key":"10.1016\/j.cgh.2013.05.020_bib38","doi-asserted-by":"crossref","first-page":"e24S","DOI":"10.1378\/chest.11-2291","article-title":"Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Garcia","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cgh.2013.05.020_bib39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/14017430903388334","article-title":"Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery","volume":"44","author":"Landenhed","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.cgh.2013.05.020_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2146\/ajhp100133","article-title":"Is there a role for fondaparinux in perioperative bridging?","volume":"68","author":"Garwood","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cgh.2013.05.020_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1160\/TH11-05-0358","article-title":"Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA)","volume":"106","author":"Pengo","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cgh.2013.05.020_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2013.05.020_bib43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","article-title":"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding","volume":"172","author":"Witt","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2013.05.020_bib44","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2013.05.020_bib45","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2010.05.013","volume":"56","author":"Holmes","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cgh.2013.05.020_bib46","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/CIRCULATIONAHA.112.102335","article-title":"Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation","volume":"125","author":"Kleiman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cgh.2013.05.020_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1586\/ecp.12.19","article-title":"Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives","volume":"5","author":"Kalantzi","year":"2012","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.cgh.2013.05.020_bib48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/clc.22094","article-title":"Pharmacodynamic impacts of proton, pump inhibitors on the efficacy of clopidogrel in vivo-a systematic review","volume":"36","author":"Chen","year":"2013","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cgh.2013.05.020_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0b013e318203f38d","article-title":"Antiplatelet drugs: a review of their pharmacology and management in the perioperative period","volume":"112","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1016\/j.cgh.2013.05.020_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000338045","article-title":"Protease-activated receptor-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with acute coronary syndrome","volume":"47","author":"Leonardi","year":"2012","journal-title":"Adv Cardiol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513007313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356513007313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:13:09Z","timestamp":1761541989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356513007313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1542356513007313"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.05.020","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Anticoagulant and Antiplatelet Agents: A Primer for the Gastroenterologist","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}